75N95022Q00137_product_description.pdf

PDF 142 KB Posted

Attached to
Qiagen Ingenuity Pathway Analysis (IPA) Analysis Match Explorer CL Software Federal contract opportunity
Solicitation number
75N95022Q00137
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

View the file

Other files for this federal contract opportunity

Other files attached to Qiagen Ingenuity Pathway Analysis (IPA) Analysis Match Explorer CL Software, newest first.
File Type Posted
FAR_52.204-26_Oct_2020.pdf PDF
FAR 52.212-4 Addendum.pdf PDF
Invoicing Instructions 20210210.pdf PDF
FAR_52.204-24_Nov_2021.pdf PDF
FAR 52.212-5 (Jan 2022).pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose: Ingenuity Pathway Analysis – one institute-wide floating annual license

2. Background Information and Objective: Aging and age-related diseases are caused by complex interplay of many different factors. To better understand the cause-effect relationship, the finding of high-throughput assays such as RNA sequencing or microarray needs to be looked at in the context of biological processes and pathways. Ingenuity Pathway Analysis software will help the researchers to look at altered biological processes and pathways.

3. Generic Name of Product: software license

4. Purchase Description:

Product Name

Product Code

Quantity

Term (months)

Term (days)

Contract Effective Date

Contract End Date

IPA Analysis Match Explorer CL 836506 1 12.00 April 1, March 31,

5. Salient characteristics: IPA is an all-in-one, web-based software application that enables researchers to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays; phosphoproteomics, metabolomics, proteomics, and RNA- Seq experiments; and small-scale experiments that generate gene and chemical lists.

6. Quantity: 1

7. Delivery Date: N/A

8. Period of Performance: April 1, 2022 – March 31, 2023

9. Option(s): N/A

File details come from the government source that posted it. Updated .